Home AngioSense

AngioSense

acquired
-
A Biotechnology Company
Basic
Enterprise Profile

Basic Information

AngioSense has developed needle-free injection technology for cardiovascular and cancer treatment applications, delivering drugs, biologics, and cell injections to different organs of the body for therapeutic and diagnostic purposes.
AngioSense
United States of America
unclear
--
--

Enterprise Profile

Concept
Cardiovascular Disease